Foundations of Pediatric Dermatology Certificate Course
Release Date: August 15, 2023
Expiration Date: August 15, 2024

Activity Overview
The Foundations of Pediatric Dermatology Certificate Course is a six (6) module activity designed for any healthcare professional seeking to learn the fundamentals of pediatric dermatology and the core principles in the management and treatment of atopic dermatitis, acne and pigmentary disorders, hair and scalp disorders, molluscum and considerations in skin of color. The course will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in their respective practices and will culminate in a “When to Refer” guideline takeaway.

Target Audience
This activity is designed for an audience of US-based Pediatricians, Advanced Practice Providers, Physician Assistants, Residents and Fellows of dermatology practices that treat pediatric and adolescent patients.

Learning Objectives
Upon completion of the educational activity, participants should be able to:

• Understand the events and causes involved in the development of acne lesions
• Review and understand pigmentary disorders, their classifications, and evidence-based guidelines for management
• Evaluate the evidence for emerging therapies in relation to acne and major pigmentary disorders
• Identify and describe the complex and multifactorial pathophysiology of atopic dermatitis (AA)
• Review and understand strategies for the management of atopic dermatitis and its associated comorbid conditions
• Develop treatment plans for patients with atopic dermatitis that reflect evidence-based guidelines and strategies to optimize short-term control and long-term management of the disease
• Define and describe the clinical presentations and features, natural history, and common complications of common skin conditions (i.e.: psoriasis, seborrheic dermatitis, pityriasis rosea, urticaria/hives, etc.)
• Develop plans to improve adherence to evidence-based clinical guidelines in practice for common skin conditions
• Review current and emerging therapies that hold promise for the effective treatment of common skin conditions
• Examine and understand common skin conditions (i.e.: sun protection, diaper dermatitis, infantile hemangioma, etc.), their prevalence, and clinical presentations
• Review clinical guidelines for the management of common skin conditions
• Understand the clinical evidence and mechanisms of action of topical and/or systemic drugs used to treat common skin conditions
• Identify the etiology and pathophysiology of hair disorders and scalp conditions (i.e.: alopecia arreata, hair loss, etc.)
• Examine and understand the typical presentations of hair disorders and scalp conditions
• Review the evidence and clinical guidelines for the management of hair disorders and scalp conditions
• Understand the causes of common dermatological infections (i.e.: impetigo, tinea, scabies, verruca vulgaris/warts, molluscum, etc.)
• Review and understand the typical presentations of common dermatological infections and clinical guidelines for management
• Evaluate and understand current and future treatment options for dermatological infections
• Diagnose, examine, and manage dermatologic conditions of the skin and hair in pediatric patients with skin of color

Credit Claim
A link to claim credit for this activity will be displayed inside the course, once all components have been completed. Please claim your credit by August 15, 2024.

Please note this course is released in 2 parts, with modules 4-6 releasing August 15, 2024. No credit may be claimed before this date.

Criteria for Success
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate.  You must participate in the entire activity to receive credit. If you have questions about this CE activity, please contact AKH Inc at ketrea@akhcme.com.

CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Medical Group. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Assistant
	AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.0 AAPA Category 1 CME credits. Approval is valid until August 15, 2024. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Tarsus Medical Group. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 6.0 contact hour(s) (which includes 4.0 hour(s) of pharmacology).

Commercial Support
This activity is supported from an independent medical education grant from CeraVe.

Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.

If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.